Hans Hull

Affiliations

  • Chief Business Officer at Pliant Therapeutics Inc. (PLRX), 2024-01-24
  • Chief Executive Officer at Avalanche Biotechnologies Inc. (AAVL), 2015-08-25
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PLRX $17.23 9,786 Officer 185,069 2024-01-17 Filing
PLRX $20.01 20,050 Officer 194,855 2023-08-04 Filing
PLRX $20.00 1,800 Officer 206,114 2023-08-03 Filing
PLRX $20.00 13,069 Officer 206,114 2023-08-03 Filing
PLRX $18.01 17,937 Officer 219,183 2023-07-17 Filing